Neoadjuvant Chemotherapy Versus Upfront Surgery for Resectable Liver Metastases from Colorectal Cancer: a Multicenter, Propensity Score-Matched Cohort Study.
Fumitoshi HirokawaMasaki UenoTakuya NakaiMasaki KaiboriTakeo NomiHiroya IidaShogo TanakaKoji KomedaShinya HayamiHisashi KosakaDaisuke HokutoShoji KuboKazuhisa UchiyamaPublished in: Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract (2021)
Patients with resectable CRLM should undergo upfront surgery, because NAC did not improve OS after initial treatment in these patients.
Keyphrases
- liver metastases
- neoadjuvant chemotherapy
- locally advanced
- minimally invasive
- coronary artery bypass
- end stage renal disease
- chronic kidney disease
- newly diagnosed
- ejection fraction
- rectal cancer
- squamous cell carcinoma
- sentinel lymph node
- lymph node
- transcription factor
- surgical site infection
- prognostic factors
- patient reported outcomes
- cross sectional
- coronary artery disease
- atrial fibrillation
- patient reported